Risk adapted dose-intensified postoperative Tomotherapy RT in prostate cancer using a SIB.

被引：0

作者：

Beck, M. ^{[1
]}

Barelkowski, T. ^{[1
]}

Thieme, A. H. ^{[1
]}

Wecker, S. ^{[1
]}

Kaul, D. ^{[1
]}

Wlodarczyk, W. ^{[1
]}

Budach, V. ^{[1
]}

Wust, P. ^{[1
]}

Ghadjar, P. ^{[1
]}

机构：

[1] Charite, Dept Radiat Oncol, Berlin, Germany

来源：

RADIOTHERAPY AND ONCOLOGY | 2017年 / 123卷

关键词：

D O I：

10.1016/S0167-8140(17)31760-7

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

EP-1325

引用

页码：S710 / S711

页数：2

共 50 条

[41] A phase II study of stereotactic body radiation therapy for low -intermediate-high-risk prostate cancer using helical tomotherapy: dose-volumetric parameters predicting early toxicity
Macias, Victor A.
Blanco, Manuel L.
Barrera, Immaculada
Garcia, Rafael
[J]. FRONTIERS IN ONCOLOGY, 2014, 4
[42] Feasibility Study of Using the HybridArc Treatment Technique for Preoperative Irradiation of Rectal Cancer: Comparison of Dose Patterns in Lesion and Organ at Risk with the Tomotherapy
Reynders, T.
Gevaert, T.
Engels, B.
Verellen, D.
De Coninck, P.
Duchateau, M.
Tournel, K.
Depuydt, T.
De Ridder, M.
[J]. MEDICAL PHYSICS, 2011, 38 (06)
[43] Feasibility study of using the HybridArc treatment technique for preoperative irradiation of rectal cancer: comparison of dose patterns in lesion and organ at risk with the Tomotherapy
Gevaert, T.
Engels, B.
Verellen, D.
De Coninck, P.
Duchateau, M.
Reynders, T.
Tournel, K.
Depuydt, T.
De Ridder, M.
[J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 (10) : 684 - 684
[44] Comparing the prediction of prostate biopsy outcome using the Chinese Prostate Cancer Consortium (CPCC) Risk Calculator and the Asian adapted Rotterdam European Randomized Study of Screening for Prostate Cancer (ERSPC) Risk Calculator in Chinese and European men
Rui Chen
Jan F. M. Verbeek
Yue Yang
Zijian Song
Yinghao Sun
Monique J. Roobol
[J]. World Journal of Urology, 2021, 39 : 73 - 80
[45] Comparing the prediction of prostate biopsy outcome using the Chinese Prostate Cancer Consortium (CPCC) Risk Calculator and the Asian adapted Rotterdam European Randomized Study of Screening for Prostate Cancer (ERSPC) Risk Calculator in Chinese and European men
Chen, Rui
Verbeek, Jan F. M.
Yang, Yue
Song, Zijian
Sun, Yinghao
Roobol, Monique J.
[J]. WORLD JOURNAL OF UROLOGY, 2021, 39 (01) : 73 - 80
[46] DAILY MVCT ANALYSIS TO DETERMINE ACTUAL DOSE RECEIVED, COMPARED TO PLANNED DOSE, BY NORMAL STRUCTURES DURING HYPO-FRACTIONATED HELICAL TOMOTHERAPY TREATMENT IN HIGH RISK PROSTATE CANCER PATIENTS
Chowdhury, R.
Small, C.
MacKenzie, M.
Fallone, G.
Pearcey, R.
Fields, C.
Pervez, N.
[J]. RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S10 - S10
[47] Matched-pair analysis of prostate cancer patients with a high risk of positive pelvic lymph nodes treated with and without pelvic RT and high-dose radiation using high dose rate brachytherapy
Vargas, Carlos E.
Demanes, Jeffrey
Boike, Thomas P.
Barnaba, Marie-Claire
Skoolisariyaporn, Pat
Schour, Lionel
Gustafson, Gary S.
Gonzalez, Jose
Martinez, Alvaro A.
[J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2006, 29 (05): : 451 - 457
[48] Late toxicity predictors in high-risk prostate cancer radiotherapy using accumulated delivered dose
Ong, A.
Panettieri, V.
Dimmock, M.
Tuan, J.
Tan, H. Q.
Wright, C.
[J]. RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1905 - S1906
[49] RESULTS OF A DOSE ESCALATION STUDY USING A HYPOFRACTIONATED BOOST FOR ORGAN CONFINED INTERMEDIATE RISK PROSTATE CANCER
Kotzen, J.
[J]. RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S270 - S270
[50] Adjuvant phase III trial comparing an intensified dose-dense adjuvant therapy with EnPC compared to a dose-dense, dose-adapted therapy with dtEC-dtD in patients with primary high risk breast cancer
Noeding, S.
Forstbauer, H.
Wachsmann, G.
Ober, A.
Schneeweiss, A.
Christensen, B.
von Abel, E.
Grischke, E-M
Hoeffkes, H-G
Klare, P.
Ko, Y-D
Schmatloch, S.
Burchardi, N.
Loibl, S.
von Minckwitz, G.
Moebus, V
[J]. ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 111 - 112

← 1 2 3 4 5 →